研究单位：[1]Peking University Cancer Hospital & Institute[2]Beijing InnoCare Pharma Tech Co., Ltd.[3]The First Affiliated Hospital of Anhui Medical University,Hefei,Anhui,China,230000[4]Peking University First Hospital,Beijing,Beijing,China,100035[5]The fifth Medical Center of People's Liberation Army General Hospital,Beijing,Beijing,China,100071[6]Beijing Cancer Hospital,Beijing,Beijing,China,100142[7]The First Affiliated Hospital of Chongqing Medical University,Chongqing,Chongqing,China,400016[8]Lanzhou University Second Hospital,Lanzhou,Gansu,China,730030[9]Harbin Medical University Cancer Hospital,Ha''erbin,Heilongjiang,China,150081[10]Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology,Wuhan,Hubei,China,430022[11]Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology,Wuhan,Hubei,China,430030[12]Hunan Cancer Hospital,Changsha,Hunan,China,410013[13]The First Affiliated Hospital of Suzhou University,Suzhou,Jiangsu,China,215006[14]The First Hospital of JiLin University,Jilin,Jilin,China,130021[15]Liaoning Cancer Hospital & Institute,Shenyang,Liaoning,China,110801[16]Shandong University Qilu Hospital,Jinan,Shandong,China,250012[17]Ruijin Hospital, Shanghai Jiao Tong University School of Medicine,Shanghai,Shanghai,China,200025[18]First Hospital of Shanxi Medical University,Taiyuan,Shanxi,China,030001[19]Sichuan Cancer Hospital,Chengdu,Sichuan,China,610000[20]Tianjin Medical University Cancer Institute & Hospital,Tianjin,Tianjin,China,300060[21]The Second Hospital of Tianjin Medical University,Tianjin,Tianjin,China,300211[22]The First Affiliated Hospital of Zhejiang University School of Medicine,Hangzhou,Zhejiang,China,310003[23]Zhejiang Cancer Hospital,Hangzhou,Zhejiang,China,310022[24]Zhejiang Provincial People''s Hospital,Hangzhou,Zhejing,China,310014
研究目的：
This is a phase 2, multicenter, single arm, open-lable study of ICP-192. The purpose of this study is to evaluate efficacy of ICP-192 in subjects with surgically unresectable or metastatic bladder urothelial cancer.
